$GTCH the application number 63197635 with the U.S. Patent
$GTCH the application number 63197635 with the U.S. Patent and Trademark Office (“USPTO”). The patent protects IP for automatic correction of manufacturing process geometrical design rules violations in microchips layout data (Professional term; DRC).
Typically, a mask layout database is created manually by a layout designer or automatically by a synthesis tool. Once the mask layout database is complete, it must go through a series of verifications in few domains. One of these checks is geometrical, to check featured dimensions according to the manufacturing process rules. Today, most of the design rule violations in the mask layout database are corrected manually by a layout designer, mainly with Analog and MIXED layout types. The designer finds each violation and manually corrects the violations by moving/modifying polygons associated with the violations. During the correction process, the layout designer may create new design rule violations and therefore the correction process may be repeated until the mask layout database does not include any design rule violations. The process of iteratively correcting the design rule violations may take several hours or even days to complete and typically significantly increase the overall layout design time. The additional time required to complete layout may also delay the production of a photomask set used to fabricate the integrated circuit.
The invention includes a method and system for automatic correction of an IC layout design rule violations to match the process rule deck reference. The automatic correction, once implemented maintains the integrated circuit mask layout electrical connectivity (LVS), reliability (RV) and Design for Manufacturing (DFM) correctness. The number of design rules has been dramatically increased over the years especially in advanced nanometer process of 7nm and below. In addition, geometrical design rules became more convoluted and highly complex to comply which requires vast amount of manual correction. Using the invention once fully developed, GBT predicts a significant IC layout productivity enhancement, enabling higher silicon yield and faster microchip’s time to market. Fabless IC design firms will be able to design and manufacture their chips faster and with lower cost.
“This type of system is a significant productivity enhancer tool within IC’s design flow and will majorly reduce the global layout design time and chip’s overall time to market factor. In addition, microchips will be able to be made smaller, which increase the silicon yield enabling much higher profit margin. Project’s design time will shrink and fabless IC design firms will be able to design more advanced chips in less time. We strongly believe that this technology will make a major impact in this arena and now working on a nonprovisional application as also on future development of such commercial EDA tool”… Said Dany Rittman, the Company’s CTO.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...
Continue Reading
Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...
Continue Reading
Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...
Continue Reading
Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...
Continue Reading
A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...
Continue Reading
Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...
Continue Reading
A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...
Continue Reading
The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...
Continue Reading
A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...
Continue Reading
Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...
Continue Reading
Top 5 Most Recently Viewed Articles
HFCL Launches Eka™ Fiber at the FTTH Conference 2025 HFCL Limited, a global pioneer in next-generation telecommunications solutions, has unveiled its innovative Eka™ Optical Fiber at the FTTH Conference 2025. Designed in collaboration with European telecom companies, this groundbreaking fiber aims to bridge the connectivity gaps within rural and urban landscapes of...
Continue Reading
CAI Software's Ambitious Move Who would've guessed, folks? Just another day in the volatile tech landscape, and we see CAI Software splashing the cash to snag PlanetTogether. This isn't just a move to puff up their chest; it's a strategic addition, placing some real weight behind their manufacturing software game. New Horizons with Advanced Planning and Scheduling...
Continue Reading
Artera Gains California Lab License to Offer Prostate Test Artera, a leader in artificial intelligence (AI) for cancer diagnostics, recently announced the attainment of its official laboratory license from the California Department of Public Health (CDPH). This important step opens the door for Artera to provide its revolutionary ArteraAI Prostate Test across one of the...
Continue Reading
Bicara Therapeutics Updates on Financial Results and Business Strategy Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, reports its financial outcomes for the third quarter of 2025 alongside strategic business insights. One of the most noteworthy achievements this quarter is the FDA granting Breakthrough Therapy Designation for...
Continue Reading
ScanTech AI's Quarterly Report Filing Details ScanTech AI Systems Inc. is pleased to announce that it has successfully filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC). This filing is a vital step for the company as it aligns with Nasdaq Listing Rule 5250(c)(1), resolving a previous noncompliance issue stemming from a delayed...
Continue Reading